"Welcome to Xi'an Atomic Medicine, the plant equipment has been installed and commissioned, and it has officially started production. In the radiopharmaceutical production base of Xi'an Atomic Pharmaceutical Co., Ltd., General Manager Sun Yu introduced that the company is committed to providing safe and reliable radiopharmaceuticals for the medical field and helping doctors to accurately diagnose and treat.
Xi'an Atomic Pharmaceutical Radiopharmaceutical Production Base is a key project of Atom Hi-Tech Co., Ltd. in Northwest China. Xi'an Atomic Pharmaceutical Co., Ltd. is located in Qinhan New Town, Xixian New District, Photovoltaic 2nd Road, affiliated to the nuclear technology application industry platform of China National Nuclear Corporation Corporation, and is a subsidiary of China Tongsheng Holding Enterprise Atomic Hi-Tech Co., Ltd.
The base has a three-story comprehensive production building with a total investment of 60 million yuan, equipped with standardized GMP workshops, mainly engaged in the research and development and production of radiopharmaceuticals, medical imaging equipment maintenance, supporting medical equipment and nuclear medicine technology application development and services. The company focuses on R&D and innovation, and continuously introduces new radiopharmaceuticals to meet the personalized needs of clinicians for the diagnosis and treatment of different diseases. According to Sun Yu, as an industry-leading radiopharmaceutical manufacturer, Xi'an Atomic Pharmaceutical has advanced production technology and strict quality management system to ensure that every bottle of drug meets international standards and relevant regulatory requirements.
Walking into the clean and tidy plant of Xi'an Atomic Medicine, all kinds of instruments and equipment are placed in an orderly manner, and the staff in white dust-free clothes are busy in their respective posts. "This is our synthesis hot chamber and sub-packaging hot chamber, mainly used for the synthesis and dispensing of radiopharmaceuticals, which can not only meet the requirements of the production environment in the good manufacturing practice of drugs, but also have the radiation protection effect of 100mm lead equivalent, which provides a compliant and clean environment for drug preparation while providing safe work security for operators. Sun Yu said.
Xi'an Atomic Medicine's radiopharmaceutical production base is equipped with high-end production and inspection equipment such as ACSI-TR19 dual-target cyclotron and high-purity germanium γ energy spectrometer. Among them, the ACSI-TR19 dual-target cyclotron has the characteristics of high energy and high beam current, which can meet the drug needs of Shaanxi Province and surrounding provinces, and also has a number of intelligent systems such as complete automatic control, self-shielding, and safety interlocking, which can ensure the safety of operating personnel and the environment.
At present, the company has business cooperation with major hospitals in Shaanxi Province, and can produce a variety of radiodiagnostic and therapeutic drugs such as technetium [99mTc] instant labeling drugs, fluoro[18F] deoxyglucose injection, and sodium iodine [131I]. In addition, we also carry out the technical application development, scientific research, diagnosis and treatment of various nuclides such as 177Lu, 153Sm, 64Cu, 124I, 131I, 32P, 89Sr, etc., sell related instruments and medical equipment, and provide overall construction solutions for nuclear medicine departments or nuclear medicine diagnosis and treatment centers. Sun Yu introduced.
The radiopharmaceuticals produced by Xi'an Atomic Medicine are widely used in tumors, bones, cardiovascular, thyroid and other fields, providing patients with non-invasive and painless examination methods. The product can help doctors conduct accurate imaging examinations, detect lesions in time, assess the condition, formulate personalized treatment plans, and improve the cure rate and quality of life.
"We are well aware of the great responsibility of radiopharmaceutical production, and have always adhered to the tenet of 'developing nuclear medicine for the benefit of mankind', providing patients with efficient and reliable radiopharmaceuticals, and making positive contributions to the cause of health. Sun Yu said, "The completion and operation of the Xi'an Atomic Pharmaceutical Radiopharmaceutical Production Base will not only help medical institutions in Northwest China to do a good job in the source quality control of radioactive drugs, but also provide impetus for the development of the health industry in Qinhan New Town." ”
Source: Qinhan New Town
Editor: Gao Gechen